Ozempic among ‘bogus’ drug patents being challenged by U.S. to spur competition
Global News
The Federal Trade Commission sent warning letters to 10 drugmakers, taking issue with patents on popular drugs for weight loss, diabetes, asthma and other reparatory conditions.
Federal regulators are challenging patents on 20 brand-name drugs, including the blockbuster weight-loss injection Ozempic, in the latest effort by the Biden administration targeting pharmaceutical industry practices that drive up prices.
The Federal Trade Commission on Tuesday sent warning letters to 10 drugmakers, taking issue with patents on popular drugs for weight loss, diabetes, asthma and other reparatory conditions. The letters allege that certain patents filed by Novo Nordisk, GlaxoSmithKline, AstraZeneca and seven other companies are inaccurate or misleading.
Brand-name drugmakers use patents to protect their medicines and stave off cheaper, generic medicines. Most blockbuster drugs are protected by dozens of patents covering various ingredients, manufacturing processes and intellectual property. Generic drugmakers can only launch their own cheaper versions if the patents have expired or are successfully challenged in court.
“By filing bogus patent listings, pharma companies block competition and inflate the cost of prescription drugs, forcing Americans to pay sky-high prices for medicines they rely on,” said FTC Chair Lina Khan, in a statement.
Ozempic is part of a class of drugs that were originally developed to treat diabetes but which have recently been approved to treat obesity, generating a surge in prescribing. Medicare spending on the drugs has also spiked in recent years.
The drug’s Danish manufacturer, Novo Nordisk, declined to comment.
FTC’s latest announcement follows a similar action in September when regulators challenged more than 100 patents held by drugmakers, including Abbvie, AstraZeneca and Boehringer Ingelheim.
Companies receiving the letters have 30 days to withdraw or update their patent listings, or “certify under penalty of perjury” that they are legitimate, according to the FTC. The patents are registered with the Food and Drug Administration, which reviews and approves new drugs.
B.C. health authorities have announced the first case of a human avian flu infection acquired in Canada, with the teenage patient in critical condition in hospital.
People have been hearing a lot about H5N1 bird flu — or highly pathogenic avian influenza — since a B.C. teen became the first human to get the virus in Canada and is in hospital.
The Liberal government and the NDP negotiated the substance of a pharmacare bill as part of their now-defunct supply-and-confidence agreement.
Kennedy ran as an independent presidential candidate but gave Trump his endorsement with a promise to have a role in health policy in the next Trump administration.
Emergency services are at the scene of a train derailment Thursday morning on Montreal's south shore, where they are urging citizens to stay away from the area.
"I was yelling at them saying get the F** away it’s a wild animal," resident Josh Merrin told Global News. "Sorry about my language."
H5 bird flu is widespread in wild birds worldwide and is causing outbreaks in poultry and U.S. dairy cows, with several recent human cases in U.S. dairy and poultry workers.
The Calgary Zoo announced that one of its lowland gorillas unexpectedly passed away on November 12, 2024.
Edmontonians have had mixed feelings and now the city is asking people to share their thoughts officially. The findings of a survey could bring some changes.
Dr. Anna Wolak, a family physician in Vancouver, said many parents are likely having flashbacks to the beginning of the COVID-19 pandemic, despite this flu being a single case.
WHO acknowledged that testing for mpox is still not widespread, making it difficult to understand how exactly the virus is spreading.